Rejuran treatment: everything you need to know for skin rejuvenation

KEIT Day Hospital has clinical facilities dedicated to aesthetic medicine treatments, organised to ensure appropriate standards of hygiene, procedural precision and patient comfort.
For Rejuran treatment, the doctor assesses skin condition and identifies areas showing dehydration, loss of elasticity, fine lines or irregularities in skin texture. The product is administered through microinjections, using fine, sterile, single-use needles and techniques selected according to the anatomical characteristics of the area.
The organisation of the clinical facilities and the availability of medical resources allow the different stages of the procedure to be managed, from skin preparation to observation immediately after treatment.

KEIT Day Hospital works with medical professionals experienced in aesthetic medicine, skin biostimulation treatments and injectable techniques. For Rejuran treatment, knowledge of skin anatomy is essential for identifying injection areas, selecting the appropriate depth and distributing the product in a controlled manner.
Treatment is personalised according to skin quality, the presence of fine lines and the degree of elasticity loss, prioritising a gradual and natural improvement in the skin's appearance.
An additional advantage is the presence of a multidisciplinary medical team within KEIT Day Hospital, allowing specialists in anaesthesia and intensive care or other medical disciplines to be involved when additional assessments or specific medical assistance are required.

Before Rejuran treatment, the doctor carries out an individual assessment of skin hydration, elasticity, texture and the presence of superficial wrinkles. The consultation includes taking a medical history, with particular attention to allergies, previous reactions to fish-derived products, medications being taken, previous aesthetic treatments, skin infections and possible contraindications.
The assessment makes it possible to identify areas that may benefit from treatment and establish a personalised treatment plan. The selected formulation, number of sessions and intervals between applications are determined according to the initial skin condition, the product's indications and the patient's aesthetic goals. When Rejuran is not the most appropriate solution, the doctor assesses possible alternative treatments and discusses their benefits and limitations.

KEIT Day Hospital follows hygiene and infection prevention protocols that include disinfecting clinical areas, skin antisepsis and the use of sterile, single-use devices during injectable treatments. For Rejuran treatment, particular attention is paid to skin preparation, needle handling and checking the product packaging.
Rejuran is a range of products containing purified polynucleotides derived from salmon DNA, used in treatments aimed at improving skin quality. The choice of formulation and administration method takes into account the product's instructions for use and individual needs. The brand name, batch number, quantity administered and treated areas are recorded in the clinical documentation, ensuring traceability of the procedure.

Rejuran treatment is a minimally invasive procedure, generally performed without general anaesthesia. When necessary, a topical anaesthetic may be applied to improve patient comfort. Polynucleotide-based injectable treatments also require medical expertise and adequate preparation for managing complications.
In addition to temporary effects such as redness, swelling and minor bruising, allergic reactions, infections, nodules or persistent inflammation may occur. Prompt recognition of symptoms and activation of appropriate medical protocols are essential for safely managing any complications.
One of KEIT Day Hospital's distinguishing features is the availability of hospital infrastructure and a multidisciplinary medical team. The facility has three equipped operating theatres, specialists in anaesthesia and intensive care, equipment for monitoring vital signs, emergency management devices and a postoperative recovery room. These resources provide additional medical support, alongside the specific protocols required to manage complications associated with injectable treatments.

At KEIT Day Hospital, patient care continues after Rejuran treatment has been completed. Patients receive personalised instructions on skincare, hydration, sun protection and precautions to follow during the first few days.
Follow-up is determined according to the patient's individual response to treatment. Follow-up appointments, when indicated, allow the doctor to assess changes in skin texture, elasticity and hydration, while checking for any persistent reactions and the need for additional sessions.
For international patients, care may also continue remotely through communication with medical staff and guidance on necessary follow-up appointments. KEIT Day Hospital also provides an emergency contact number, available 24 hours a day, 7 days a week.

KEIT Day Hospital places particular emphasis on transparent information and treatment documentation. Before Rejuran treatment, patients receive explanations about the selected formulation, the areas to be treated, the approximate number of sessions, expected benefits, the limitations of the available clinical evidence and potential risks.
Clinical documentation records the product's brand name, batch number, quantity administered and injection sites, ensuring traceability of the procedure. When appropriate and with the patient's consent, photographic documentation is taken to compare the initial skin condition with the results obtained. The informed consent form, treatment quotation and administrative documentation also allow patients to understand the clinical and financial aspects of the treatment process before undergoing treatment.